Paul Barclay

Paul Barclay

Company: Leo Pharma

Job title: Vice President, Global Program Head


Topical JAK Inhibitors for the Treatment of Chronic Hand Eczema & other Complex Inflammatory Skin Disorders 11:30 am

• Understanding the complex pathophysiology and disease burden of Chronic Hand Eczema • Summarizing Phase 2 efficacy and safety of Delgocitinib, a topical pan-JAK inhibitor • Exploring other potential dermatological conditions where JAK inhibitors are being evaluatedRead more

day: Day 2 AM - Track 2

Panel Discussion: Evaluate the Current Challenges, Approaches & Opportunities in Treating Inflammatory & Autoimmune Skin Conditions? 9:30 am

• A year on from the DDD Summit in 2020: What have we learnt? • How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for dermatological inflammatory conditions? • Discussing barriers to progress and strategies to address theseRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.